Paushak Limited (532742) Fair Value & Analysis
Other · IN · Market cap ₹11.5B
Fair value as of: Aug 13, 2026
From 16 valuation models · updated 5 days ago
Fair value updated Aug 13, 2026, revised from ₹215.36 to ₹319.99 (+48.6%) since Jul 7, 2026.
A solid business, but screening 58% overvalued on our models.
What matters now
- The price sits above even our optimistic bull case (₹411.57). The favourable scenario is already priced in.
- Solid but not exceptional quality (54/100) and above fair value, neither a clear bargain nor a standout compounder.
- A fairly wide model range (₹227.27 to ₹411.57) leaves room in how you read the outcome.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 13, 2026.
How to read this chart
60‑month range ₹345.60 – ₹1,495 · fair‑value band ₹227.27 – ₹411.57 · the ₹754.45 price screens above the ₹319.99 fair value. Dashed = 300-day average. As of Aug 13, 2026.
Analysis
Paushak Limited (532742) currently trades at ₹754.45, while our model-based Fair Value estimate is ₹319.99, implying the stock looks roughly 57.6% overvalued today. The Quality Score stands at 54/100 (solid quality), in the Other sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: high).
Over the trailing twelve months, Paushak Limited generated revenue of ₹1.3B at a net margin of 24.8%. Revenue declined 13.9% year over year. It earns a return on equity of 14.8%. Net debt stands at ₹769M. Fundamentals as of Aug 13, 2026
Our scenario range runs from ₹227.27 (bear case) to ₹411.57 (bull case); at ₹754.45, the current price sits above that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 24% below its 52-week high and 120% above its 52-week low, currently below its 200-day average. For context, the median of 10 Other peers we cover trades at -24% fair-value upside, at -58%, 532742 screens richer than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 16 models by family
Widest divergence: Growth Earnings (₹341.53) versus Dividend Discount (₹61.74). Highest evidence: Residual Income (76).
Notify me when 532742 reaches fair value
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Aug 13, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 52 · Market factors (momentum, volatility) 49
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
Paushak Limited develops, manufactures, and sells phosgene based specialty chemicals and intermediates in India and internationally. Its products include isocyanates, chloroformates, carbonates/carbamates, carbamoyl chlorides, and others. The company primarily serves pharma, agro, and specialty chemical companies.
Full company description
Paushak Limited develops, manufactures, and sells phosgene based specialty chemicals and intermediates in India and internationally. Its products include isocyanates, chloroformates, carbonates/carbamates, carbamoyl chlorides, and others. The company primarily serves pharma, agro, and specialty chemical companies. Paushak Limited was incorporated in 1972 and is based in Vadodara, India.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2022 – FY2026 · reported fiscal years
Paushak Limited reported revenue of ₹2.2B in FY2026 versus ₹1.5B in FY2022, a compound +9.9%/yr. Reported net income was ₹393M in FY2026, compounding +1.1%/yr from FY2022.
532742 screens 58% overvalued. Compare with Federal Home Loan Mortgage Corporation →
Peer Group
Other · 373 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Other median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
VALUE 0: the price sits above our fair-value range.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Other stocks, each showing price versus our Fair Value estimate (as of Aug 13, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Federal Home Loan Mortgage Corporation FREJO | $15.58 | $51.90 | +233% |
| 533278 533278 | ₹409.15 | ₹660.78 | +62% |
| Nestl?? India Limited 500790 | ₹1,497 | ₹191.93 | -87% |
| ITC Limited 500875 | ₹279.50 | ₹212.74 | -24% |
| Wipro Limited 507685 | ₹183.80 | ₹193.38 | +5% |
| 540376 540376 | ₹4,054 | ₹1,542 | -62% |
| 540777 540777 | ₹537.50 | ₹149.72 | -72% |
| Lupin Limited 500257 | ₹2,265 | ₹1,983 | -12% |
| Dabur India Limited 500096 | ₹413.80 | ₹122.93 | -70% |
| 540719 540719 | ₹1,835 | ₹872.41 | -52% |
Compare Paushak Limited with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
Frequently asked questions
Is Paushak Limited (532742) overvalued or undervalued?
What is the fair value of 532742?
What is the quality score of 532742?
What is the revenue of Paushak Limited (532742)?
What is the net profit margin of 532742?
Does Paushak Limited pay a dividend?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track Paushak Limited and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.